24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
AstraZeneca
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:54
In Musk we trust? Starlink is a double-edged sword in modern warfare
20:23
Full list of Israeli startup M&As in 2023
20:18
Blockchain unicorn Fireblocks acquires Australian tokenization startup BlockFold
18:47
Crypto fund Collider wins $1 million grant for discovering critical security breach
More stories
Buzz
Most popular
Daily
Weekly
1
Is the iPhone 15 Pro worth the upgrade? In-depth review and analysis
2
Palo Alto Networks in advanced negotiations to acquire Dig Security in $300-$400 million deal
3
Senser emerges from stealth with $9.5 million in Seed
4
Black Cube Moves into Larger, Fancier Headquarters
5
Palo Alto Networks in negotiations to acquire Talon Cyber Security in $600 million deal
More news
AstraZeneca
16 stories about AstraZeneca
Six Israeli startups selected to participate in BeyondBio SCALE program
18.12.22
|
CTech
Improving cancer treatment, enabling efficient ways for sharing of data for advanced research, and AI for predicting drug safety, are all among the innovative solutions developed by the six startups selected for BeyondBio SCALE - a joint innovation program of AstraZeneca, Accenture, Clalit and AWS
AstraZeneca, Accenture, AWS and Clalit Health Services launch BeyondBio SCALE startup program
02.08.22
|
James Spiro
The program is expected to start in November and run until next summer, and will assist startups to expand into markets with the help of program collaborators and their clinical, commercial, and technical expertise
The digital health revolution: PlayBeyondBio’s startup cohort comes to a close
06.04.22
|
Doron Broitman
The program, led by AstraZeneca, the JVP venture capital fund, the international consulting firm Accenture, Margalit Startup City, Amazon Web Services (AWS) and Shaare Zedek Medical Center in Jerusalem, lasted for six months and included eight startups
AstraZeneca innovation hub seeking Israeli tech as it broadens search for innovation
03.04.22
|
Allon Sinai
“Imagine the power of merging game developers with behavioural scientists together with tech nerds and medics in an environment of 3,000 pharmaceutical scientists,” said Magnus Bjorsne, CEO of the pharmaceutical giant’s BioVentureHub, which is eager to bring on board Israeli startups
To spur innovation, tech ecosystems can’t afford to overlook academia
09.08.21
|
Anna Pellivert
Curiosity Driven Research born from academia is vital in order to keep the best minds tackling the biggest questions in science.
PlayBeyondBio begins second cohort looking for health solutions in a post-Covid world
03.06.21
|
James Spiro
The initiative is being run by AstraZeneca, JVP, Accenture, and Margalit Startup City
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab
27.12.20
|
James Spiro
The lab, which is set to research digital health and computational biology, has a government budget of $9.9 million
Israeli medical-device startup offers a breath of fresh air
24.12.20
|
Yafit Ovadia
BreezoMeter wants to monitor the air you breath, and has developed a platform to keep track of air quality to help those with lung conditions
Will the quickly developed vaccines deliver Covid-19 a knockout blow?
13.12.20
|
Sophie Shulman
An urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist
24.11.20
|
Yafit Ovadia
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
As the Covid-19 vaccine arms race intensifies, big money is at risk
10.08.20
|
Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
Pharmaceutical Company AstraZeneca Launches Digital Health Program in Israel
27.11.19
|
Meir Orbach
Alongside funding, the program will provide Israeli startups with mentorship and training
CTech’s Tuesday Roundup of Israeli Tech News
03.04.18
|
CTech
IDB’s bid for Israeli satellite operator Spacecom nearing closure. AstraZeneca signs deal with cancer immunotherapy company Compugen
AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen
03.04.18
|
Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
Soriot's Teva Appointment Unlikely, Says Activist Investor
06.08.17
|
Golan Hazani
Teva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"
Teva in Talks to Appoint AstraZenca's Pascal Soriot as CEO
18.07.17
|
Golan Hazani
Mr. Soriot has met with the company’s search committee and its chairman and expressed his agreement to serve as its next CEO, people familiar with the matter said
Please ensure Javascript is enabled for purposes of
website accessibility